James Smith- pharma
- October 21, 2026
- 27 views
James SmithHepatitis B Approval: Proven Cure Strategy Gains Focus
Hepatitis B Approval highlights GSK’s innovative approach to treatment.
- James Smith
- pharma
- October 14, 2026
- 31 views
FDA Approval Pill: Worth a Proven $400M+ Opportunity
FDA approval pill could revolutionize treatment and is projected to generate over $400 million in revenue.
- James Smith
- pharma
- September 29, 2026
- 49 views
FDA Approval Bone Drug: Teva’s Proven New Treatment
FDA approval bone drug marks a significant advancement in treatment options.
